Medexus Pharmaceuticals Inc. (TSX:MDP)

Canada flag Canada · Delayed Price · Currency is CAD
3.100
-0.060 (-1.90%)
At close: Mar 6, 2026
15.24%
Market Cap 100.13M
Revenue (ttm) 136.34M
Net Income (ttm) -372.95K
Shares Out 32.30M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE 7.43
Dividend n/a
Ex-Dividend Date n/a
Volume 50,900
Average Volume 45,646
Open 3.160
Previous Close 3.160
Day's Range 3.100 - 3.160
52-Week Range 1.960 - 3.610
Beta 1.87
RSI 62.60
Earnings Date Feb 11, 2026

About Medexus Pharmaceuticals

Medexus Pharmaceuticals Inc. operates as a pharmaceutical company in Canada and the United States. The company focuses on various therapeutic areas comprising allergy, dermatology, hematology, oncology, rheumatology, and rare diseases. Its primary products include IXINITY, an intravenous recombinant factor IX therapeutic for use in patients with hemophilia B; Rasuvo and Metoject, a formulation of methotrexate designed to treat rheumatoid arthritis and other auto-immune diseases; Rupall, a prescription allergy medication; GRAFAPEX, an injection ... [Read more]

Sector Healthcare
Founded 2000
Employees 91
Stock Exchange Toronto Stock Exchange
Ticker Symbol MDP
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.